ANVESHAN
Theme
Create account
quant Money Managers Limited · Sectoral/ Thematic

quant Healthcare Fund

Equity Scheme - Sectoral/ Thematic Direct plan, growth benchmark: NIFTY Healthcare TRI launched 27 Jun 2023 open-ended

At a glance

the fund as it stands today, from public disclosures

NAV, 21 Sep 2026
₹19.45
+0.55% since 18 Sep 2026, the previous NAV
1 year
18.9%
return
3 years
22.0%
a year
5 years
not enough history
Since launch
22.6%
a year, over 3.1 years
Assets (AUM)
₹397 Cr
Aug 2026 factsheet
Expense ratio, Direct / Regular
1.49% / 3.12%
a year, as of Aug 2026
Holdings
25
top ten are 100% of the fund · Aug 2026
Disclosed history
3.1 yrs
Aug 2023 – Aug 2026 · 5 of 11 checks could run
Fund managers
Ankit Pande · since at least Feb 2024Sandeep Tandon · since at least Feb 2024Sanjeev Sharma · since at least Feb 2024Ayusha Kumbhat · since Mar 2025Varun Pattani · since Mar 2025Sameer Kate · since Apr 2025Yug Tibrewal · since Apr 2025

What only Anveshan can tell you

measured from the disclosures, not quoted from a brochure — each links to how it was done

P5Cost, measured

Regular plan costs 1.96% a year more than Direct

₹1,11,967 on ₹1 lakh over ten years. Same portfolio, two prices — the difference is what the Regular plan's distribution costs you, read from the two NAVs.

See how it is measured →
P7Whose record

Run by Ankit Pande for at least 2.5 yrs

with Sandeep Tandon, Sanjeev Sharma, Ayusha Kumbhat, Varun Pattani, Sameer Kate, Yug Tibrewal · the factsheet archive starts Feb 2024, so this is a floor. A return earned before they arrived is the house's record, not theirs — the tenure table shows the fund against its category over exactly their months.

Ankit Pande's other funds →
NAVTracking gap

Not replicated: the portfolio cannot be priced line by line in this build.

Each day, the NAV the fund published against the NAV its last disclosed portfolio would have produced at that day's prices. A gap that opens and stays is a change the fund has made and not disclosed yet.

See the daily gap →
P4Consistency

Beat its category in 100% of three-year stretches, and averaged +7.2 points a year across all of them

3 rolling windows since 2023 · ahead by 7.2 points a year when it won — and never lost one. A single five-year figure depends on the day you look; the share of stretches won does not — and the average margin says whether winning often was worth anything.

See every window →

headline and record disagree 2 checks found the headline number and the underlying record pointing different ways — marked on the cards below.

NAV and drawdown

Direct plan, growth class · as of 21 Sep 2026

Month-end NAV, indexed to 100 at Jul 2023

100150Jul 2023May 2024Mar 2025Dec 2025Sep 2026Jul 2023: NAV ₹10.27Aug 2023: NAV ₹10.62Sep 2023: NAV ₹10.77Oct 2023: NAV ₹10.35Nov 2023: NAV ₹11.70Dec 2023: NAV ₹12.26Jan 2024: NAV ₹13.38Feb 2024: NAV ₹13.61Mar 2024: NAV ₹13.27Apr 2024: NAV ₹14.01May 2024: NAV ₹14.16Jun 2024: NAV ₹14.90Jul 2024: NAV ₹16.58Aug 2024: NAV ₹17.46Sep 2024: NAV ₹17.48Oct 2024: NAV ₹16.74Nov 2024: NAV ₹16.65Dec 2024: NAV ₹16.17Jan 2025: NAV ₹15.34Feb 2025: NAV ₹13.55Mar 2025: NAV ₹14.50Apr 2025: NAV ₹15.05May 2025: NAV ₹15.89Jun 2025: NAV ₹16.28Jul 2025: NAV ₹15.86Aug 2025: NAV ₹15.33Sep 2025: NAV ₹15.49Oct 2025: NAV ₹15.95Nov 2025: NAV ₹15.91Dec 2025: NAV ₹15.59Jan 2026: NAV ₹14.96Feb 2026: NAV ₹15.65Mar 2026: NAV ₹14.82Apr 2026: NAV ₹16.04May 2026: NAV ₹17.05Jun 2026: NAV ₹17.96Jul 2026: NAV ₹18.33Aug 2026: NAV ₹19.42Sep 2026: NAV ₹19.45
100150Jul 2023May 2024Mar 2025Dec 2025Sep 2026Jul 2023: NAV ₹10.27Aug 2023: NAV ₹10.62Sep 2023: NAV ₹10.77Oct 2023: NAV ₹10.35Nov 2023: NAV ₹11.70Dec 2023: NAV ₹12.26Jan 2024: NAV ₹13.38Feb 2024: NAV ₹13.61Mar 2024: NAV ₹13.27Apr 2024: NAV ₹14.01May 2024: NAV ₹14.16Jun 2024: NAV ₹14.90Jul 2024: NAV ₹16.58Aug 2024: NAV ₹17.46Sep 2024: NAV ₹17.48Oct 2024: NAV ₹16.74Nov 2024: NAV ₹16.65Dec 2024: NAV ₹16.17Jan 2025: NAV ₹15.34Feb 2025: NAV ₹13.55Mar 2025: NAV ₹14.50Apr 2025: NAV ₹15.05May 2025: NAV ₹15.89Jun 2025: NAV ₹16.28Jul 2025: NAV ₹15.86Aug 2025: NAV ₹15.33Sep 2025: NAV ₹15.49Oct 2025: NAV ₹15.95Nov 2025: NAV ₹15.91Dec 2025: NAV ₹15.59Jan 2026: NAV ₹14.96Feb 2026: NAV ₹15.65Mar 2026: NAV ₹14.82Apr 2026: NAV ₹16.04May 2026: NAV ₹17.05Jun 2026: NAV ₹17.96Jul 2026: NAV ₹18.33Aug 2026: NAV ₹19.42Sep 2026: NAV ₹19.45
100150Jul 2023May 2024Mar 2025Dec 2025Sep 2026Jul 2023: NAV ₹10.27Aug 2023: NAV ₹10.62Sep 2023: NAV ₹10.77Oct 2023: NAV ₹10.35Nov 2023: NAV ₹11.70Dec 2023: NAV ₹12.26Jan 2024: NAV ₹13.38Feb 2024: NAV ₹13.61Mar 2024: NAV ₹13.27Apr 2024: NAV ₹14.01May 2024: NAV ₹14.16Jun 2024: NAV ₹14.90Jul 2024: NAV ₹16.58Aug 2024: NAV ₹17.46Sep 2024: NAV ₹17.48Oct 2024: NAV ₹16.74Nov 2024: NAV ₹16.65Dec 2024: NAV ₹16.17Jan 2025: NAV ₹15.34Feb 2025: NAV ₹13.55Mar 2025: NAV ₹14.50Apr 2025: NAV ₹15.05May 2025: NAV ₹15.89Jun 2025: NAV ₹16.28Jul 2025: NAV ₹15.86Aug 2025: NAV ₹15.33Sep 2025: NAV ₹15.49Oct 2025: NAV ₹15.95Nov 2025: NAV ₹15.91Dec 2025: NAV ₹15.59Jan 2026: NAV ₹14.96Feb 2026: NAV ₹15.65Mar 2026: NAV ₹14.82Apr 2026: NAV ₹16.04May 2026: NAV ₹17.05Jun 2026: NAV ₹17.96Jul 2026: NAV ₹18.33Aug 2026: NAV ₹19.42Sep 2026: NAV ₹19.45

39 month-ends · ₹10.27 → ₹19.45, 1.9× since Jul 2023

Deepest fall (max drawdown)
−25.2%
13 Sep 2024 → 3 Mar 2025
Worst month
−11.7%
Feb 2025
Days to recover
487
from the deepest trough back to the old high

Drawdown is measured on the last year of daily NAV; trailing returns are CAGR of the direct growth class. A single end date decides them — the consistency card (P4) below is the record that does not, and it reports both how often the fund beat its category and by how much, because the first without the second can point the wrong way.

Holdings

Aug 2026 disclosure · 25 lines · when each was first held and the change over the last three disclosures

#HoldingSectorWeightFirst heldHeld for3-mo change
1 TREPS 01-Sep-2026 DEPO 10
money market
— 22.66% Aug 2026 1 mo +22.66%
2 Glaxosmithkline Pharmaceuticals Ltd
equity
N.A. 10.58% Feb 2026 7 mo +8.65%
3 Glenmark Pharmaceuticals Ltd 29/09/2026
derivative
— 9.83% Aug 2026 1 mo +9.83%
4 Divi's Laboratories Limited 29/09/2026
derivative
— 9.46% Aug 2026 1 mo +9.46%
5 Zydus Lifesciences Limited
equity
N.A. 9.30% Aug 2026 1 mo +9.30%
6 Pfizer Ltd
equity
N.A. 8.83% May 2024 2.3 yrs +2.91%
7 Alivus Life Sciences
equity
N.A. 8.08% Jul 2024 2.2 yrs +1.10%
8 Torrent Pharmaceuticals Ltd 29/09/2026
derivative
— 7.87% Aug 2026 1 mo +7.87%
9 Concord Biotech Limited
equity
N.A. 7.03% Jun 2026 3 mo +7.03%
10 SMS Pharmaceuticals Limited
equity
N.A. 6.71% Mar 2024 2.5 yrs -0.95%
Showing 1–10 of 25 · page 1 of 3 rows per page102550all

Largest sectors, Aug 2026 · grey: a year ago

N.A.70.3% · 86.5%
share of the book05%10%15%20%25%30%35%40%45%50%55%60%65%70%75%

By market cap, Aug 2026

Mid cap31.3%
Small / micro cap39.1%
Other34.2%
share of the book025%50%75%100%

Composition by market cap, month by month — what the fund actually held against what its label says

Large cap: 21% → 0%Mid cap: 33% → 31%Small / micro: 23% → 39%Cash & other: -4% → -5%25%50%75%Aug 2023Mar 2025Aug 2026
Large cap: 21% → 0%Mid cap: 33% → 31%Small / micro: 23% → 39%Cash & other: -4% → -5%25%50%75%Large cap 0%Mid cap 31%Small / micro 39%Aug 2023Mar 2025Aug 2026
Large cap: 21% → 0%Mid cap: 33% → 31%Small / micro: 23% → 39%Cash & other: -4% → -5%25%50%75%Large cap 0%Mid cap 31%Small / micro 39%Aug 2023Mar 2025Aug 2026
  • Large cap 0%
  • Mid cap 31%
  • Small / micro 39%
  • Cash & other -5%

The seven checks, in full

each: the plain claim, where it sits in the category, and — folded — how it is measured and the case against. A flag fires only where headline and record disagree.

P4 Consistency, not a single end date headline and record disagree

Beat its category in 100% of three-year stretches, and averaged +7.2 points a year across all of them

3 rolling windows since 2023 · ahead by 7.2 points a year when it won — and never lost one

What this means. Take every three-year stretch since the fund had a NAV, one starting each month, and ask two things of each: did it beat the typical fund in its category, and by how much. Counting the wins tells you the record does not depend on when you happen to look; averaging the margin tells you whether winning often was worth anything, because four small wins do not pay for one large loss.

How often, and by how much. The count and the average agree. It did not lose one of the 3, so the average across all of them is the average win, +7.2 points.

windows measured3windows won3average across every window+7.23 pts a year · median +7.04when ahead, by how much+7.23 pts a year over 3 windowsworst window+6.49 pts a year, ended Jul 2026best window+8.16 pts a year, ended Sep 2026non-overlapping windows in that span1 — the rolling count overlaps, this does not
Thin record. Only 3 rolling windows — under six years of NAV. The share is shown because it was measured; it is a start, not a record, and does not qualify for the home shelf until 36 windows exist.

Fund minus category, each rolling three-year window

-8.2 pp0.0 pp+8.2 ppJul 2026: fund 21.3% vs category 14.8% (3-year CAGR)Aug 2026: fund 22.3% vs category 15.3% (3-year CAGR)Sep 2026: fund 21.8% vs category 13.6% (3-year CAGR)Jul 2026Sep 2026
-8.2 pp0.0 pp+8.2 ppJul 2026: fund 21.3% vs category 14.8% (3-year CAGR)Aug 2026: fund 22.3% vs category 15.3% (3-year CAGR)Sep 2026: fund 21.8% vs category 13.6% (3-year CAGR)Jul 2026Sep 2026
-8.2 pp0.0 pp+8.2 ppJul 2026: fund 21.3% vs category 14.8% (3-year CAGR)Aug 2026: fund 22.3% vs category 15.3% (3-year CAGR)Sep 2026: fund 21.8% vs category 13.6% (3-year CAGR)Jul 2026Sep 2026
ahead of categorybehind

Each bar is one window's margin in percentage points a year. The height of the bars, not the count of green ones, is what the average across every window measures.

A modest five-year number over a record that beat its category 100% of the time. Rolling every three-year window forward month by month gives hundreds of overlapping observations instead of one. This fund was ahead of its category median in 100% of them, which points the opposite way to the headline figure. A single end date decided that headline.
How it is measured, and the case against

A fund that beats its category in most rolling three-year windows has a record; one that beats it in a few has an end date. How often it won and by how much are different questions, and this card answers both, because a fund can win four windows in five and still be behind across all five.

How often has it beaten its category, across every window?

Why this might matterRolling every three-year window forward month by month gives hundreds of overlapping observations instead of one. A single end date decides a headline five-year figure; the share of windows won cannot be flattered by when you happen to look. The average margin across every window is that share and the payoff multiplied together — win share x average beat plus loss share x average shortfall is exactly the average — so a high share bought with a few ruinous windows cannot hide behind the count.
Why it might notRolling windows overlap heavily, so they are not independent observations and the true sample is far smaller than the count suggests.
P5 Cost, measured

Regular plan costs 1.96% a year more than Direct

₹1,11,967 on ₹1 lakh over ten years

What this means. The Regular and Direct plans hold the same portfolio; the Regular one pays a distributor out of your money every day. The gap between the two NAVs is that cost, measured from the NAVs rather than quoted from a document.

on ₹1,00,000 over ten years₹1,11,967Direct vs Regular, annualised22.3% vs 20.4%measured over3.17 years
How it is measured, and the case against

The Direct plan is the same portfolio, priced differently; the divergence of the two NAVs is the cost, measured rather than quoted.

What does the Regular plan actually cost against its Direct twin?

Why this might matterSame manager, same holdings, same day. The gap between the two NAV series is the one number on this page that is knowable today rather than hoped for, and it compounds for as long as the units are held.
Why it might notA Regular plan buys advice. If that advice stops someone selling in a drawdown it can be worth more than the fee — the cost is visible and the behavioural saving is not, which makes this comparison unfair in exactly one direction.
P1 Churn, and what it bought

Turns over 143% of the portfolio a year

+0.10 pts of excess return per unit of turnover

What this means. How much of the portfolio was bought and sold in a year, computed from what the fund disclosed each month. Trading costs something certain; the extra return it is meant to buy is not.

excess return per unit of turnover+0.10 pts
How it is measured, and the case against

Turnover measured from consecutive disclosures — Σ|Δweight|/2 — costs something certain; the excess return it is meant to buy is not.

Is the trading paying for itself?

Why this might matterAMCs define their own turnover figure inconsistently. This one is computed from what the fund disclosed month to month, so two funds are comparable on it. Read it beside the excess return per unit of turnover.
Why it might notTurnover computed from month-end snapshots misses everything bought and sold inside a month, and a fund forced to sell by redemptions is charged for churn it did not choose.
P2 Conviction or inertia

Typical top-10 holding kept 10 months

What this means. How long a typical top-10 position has been in the top ten. Long-held positions are a decision; a top ten that changes every quarter is a reaction.

active sharenot yet computable — needs index constituent files
How it is measured, and the case against

The median months a top-10 position has been held separates a portfolio somebody chose from one that drifted.

How long does a top-10 position stay a top-10 position?

Why this might matterConcentration is how a manager expresses conviction, and persistence is how long they keep it. Long-held positions with a rising weight are a decision; a top ten that turns over every quarter is a reaction.
Why it might notPersistence without active share is inertia: a portfolio of 166 names that tracks its category closely has diversified away the reason to pay for it. Active share needs index constituent files, which are not loaded yet.
P3 Hit rate of the top ten

6 of 10 top picks beat their peers over the next 6 months, and averaged 8.6 points ahead of them

302 positions judged, one disclosure at a time · ahead by 20.5 points when it won, behind by 12.2 when it lost

What this means. Take each month's ten largest holdings and check whether each one beat the typical stock its category holds over the next six months, and by how much. A blended return can hide two wins and eight losses; a count of wins can hide one position that lost half its value.

How often, and by how much. The count and the average agree. Ahead by 20.5 points in the 191 positions it won and behind by 12.2 in the 111 it lost, so the average across all 302 is +8.6 points. The worst position was INE385W01011 at the Mar 2024 disclosure, 48.5 points behind.

positions judged302beat the median stock191average across every position+8.60 pts · median +6.78when ahead, by how much+20.52 pts over 191 positionswhen behind, by how much−12.15 pts over 111 positionsworst position−48.53 pts, INE385W01011 at the Mar 2024 disclosurebest position+122.18 pts, INE681B01017 at the Jun 2024 disclosure
How it is measured, and the case against

A manager's largest bets, judged one by one over the following six months, say more than the fund's blended return — and how far each one beat or missed the median stock says more than counting how many did.

Of its top-10 positions, how often did they beat the category-median stock?

Why this might matterA fund can beat its category on two positions and lose on eight; the hit rate shows the pattern the aggregate hides. The average margin then shows what the hit rate hides in turn: six winners worth a point each do not pay for four losers worth ten, and only the margin says which happened.
Why it might notSix months is short, sizing matters more than counting, and a manager who is right on the biggest position and wrong on nine small ones has done their job — the margins here are unweighted, so they answer the counting question better, not the sizing one. Overlapping disclosures judge the same position again each month it is held, so one long-held winner is counted many times. And this is a description of six months already past, not a forecast of the next six.
P6 Size against edge

₹397 Cr, 17th percentile in category; 68% of growth came from inflows

smaller than 83% of the funds in its category (216 funds) · AUM Sep 2023 → Aug 2026 · Regular plan expense ratio 3.13%

What this means. Where the fund sits by size in its category, and how much of its growth was money arriving rather than the portfolio compounding. A very large fund cannot buy what a small one can; size should buy a lower fee in return.

median holding weight, trendrisingexpense ratio, Regular / Direct3.13% / 1.51% · category median 2.38%AUM, Sep 2023 → Aug 2026₹114 Cr → ₹397 Cr (+53% a year)of that change, from flows rather than returns68% net inflows · NAV +80% over the window

Assets under management, ₹ crore, Sep 2023 – Aug 2026

100200300400Sep 2023Oct 2024Jun 2025Jan 2026Aug 2026Sep 2023: ₹114 CrDec 2023: ₹170 CrMar 2024: ₹245 CrMay 2024: ₹279 CrJun 2024: ₹287 CrJul 2024: ₹302 CrAug 2024: ₹349 CrSep 2024: ₹432 CrOct 2024: ₹454 CrNov 2024: ₹437 CrDec 2024: ₹440 CrJan 2025: ₹424 CrFeb 2025: ₹402 CrMar 2025: ₹348 CrApr 2025: ₹370 CrMay 2025: ₹396 CrJun 2025: ₹417 CrJul 2025: ₹425 CrAug 2025: ₹409 CrSep 2025: ₹384 CrOct 2025: ₹379 CrNov 2025: ₹384 CrDec 2025: ₹379 CrJan 2026: ₹362 CrFeb 2026: ₹341 CrMar 2026: ₹350 CrApr 2026: ₹327 CrMay 2026: ₹352 CrJun 2026: ₹372 CrJul 2026: ₹391 CrAug 2026: ₹397 Cr
100200300400Sep 2023Oct 2024Jun 2025Jan 2026Aug 2026Sep 2023: ₹114 CrDec 2023: ₹170 CrMar 2024: ₹245 CrMay 2024: ₹279 CrJun 2024: ₹287 CrJul 2024: ₹302 CrAug 2024: ₹349 CrSep 2024: ₹432 CrOct 2024: ₹454 CrNov 2024: ₹437 CrDec 2024: ₹440 CrJan 2025: ₹424 CrFeb 2025: ₹402 CrMar 2025: ₹348 CrApr 2025: ₹370 CrMay 2025: ₹396 CrJun 2025: ₹417 CrJul 2025: ₹425 CrAug 2025: ₹409 CrSep 2025: ₹384 CrOct 2025: ₹379 CrNov 2025: ₹384 CrDec 2025: ₹379 CrJan 2026: ₹362 CrFeb 2026: ₹341 CrMar 2026: ₹350 CrApr 2026: ₹327 CrMay 2026: ₹352 CrJun 2026: ₹372 CrJul 2026: ₹391 CrAug 2026: ₹397 Cr
100200300400Sep 2023Oct 2024Jun 2025Jan 2026Aug 2026Sep 2023: ₹114 CrDec 2023: ₹170 CrMar 2024: ₹245 CrMay 2024: ₹279 CrJun 2024: ₹287 CrJul 2024: ₹302 CrAug 2024: ₹349 CrSep 2024: ₹432 CrOct 2024: ₹454 CrNov 2024: ₹437 CrDec 2024: ₹440 CrJan 2025: ₹424 CrFeb 2025: ₹402 CrMar 2025: ₹348 CrApr 2025: ₹370 CrMay 2025: ₹396 CrJun 2025: ₹417 CrJul 2025: ₹425 CrAug 2025: ₹409 CrSep 2025: ₹384 CrOct 2025: ₹379 CrNov 2025: ₹384 CrDec 2025: ₹379 CrJan 2026: ₹362 CrFeb 2026: ₹341 CrMar 2026: ₹350 CrApr 2026: ₹327 CrMay 2026: ₹352 CrJun 2026: ₹372 CrJul 2026: ₹391 CrAug 2026: ₹397 Cr

31 points · months without a factsheet figure use AMFI's quarterly average · Regular-plan expense ratio 2.33% in Jul 2023 → 3.13% in Sep 2026

How it is measured, and the case against

Past a certain size the smaller end of a mandate becomes unreachable, and the fund starts to look like its index; what size should buy in return is a lower expense ratio.

Has the fund outgrown the universe it invests in — and did size buy a lower fee?

Why this might matterSize narrows what the manager can meaningfully hold and should lower what the investor pays. Read the AUM history beside the expense ratio: a fund that has tripled through inflows while its Regular-plan TER sits above the category median has kept the benefit of scale for the house. The flow decomposition says how much of the growth was money arriving rather than the portfolio compounding.
Why it might notScale funds research teams, and plenty of large funds have gone on compounding for decades. Inflows follow performance, so a fund growing fast is usually one that did well; the constraint is real but not automatically binding, and a TER is a ceiling the AMC can cut at any time.
P7 Whose record is this headline and record disagree

Run by Ankit Pande for at least 2.5 yrs

with Sandeep Tandon, Sanjeev Sharma, Ayusha Kumbhat, Varun Pattani, Sameer Kate, Yug Tibrewal · the factsheet archive starts Feb 2024, so this is a floor

What this means. How long the people running it now have been running it, read from the monthly factsheets. A five-year record earned under someone else is not evidence about these managers.

No category distribution for this measure yet.
running it nowAnkit Pande (since at least Feb 2024), Sandeep Tandon (since at least Feb 2024), Sanjeev Sharma (since at least Feb 2024), Ayusha Kumbhat (since Mar 2025), Varun Pattani (since Mar 2025), Sameer Kate (since Apr 2025), Yug Tibrewal (since Apr 2025)share of the fund's life under the current teamnot knowable — the archive starts Feb 2024, so the tenure is a floorchanges of hands in the archive2 — last Apr 2025

Who ran it, month by month · factsheets through Sep 2026

running it nowearlier
ManagerRoleFromToFund vs category, those months3-yr stretches won in tenure
Ankit Pande fund manager by Feb 2024† now 13.4% vs 10.2% p.a. (+3.23 pp) —
Sandeep Tandon fund manager by Feb 2024† now 13.4% vs 10.2% p.a. (+3.23 pp) —
Sanjeev Sharma fund manager by Feb 2024† now 13.4% vs 10.2% p.a. (+3.23 pp) —
Ayusha Kumbhat fund manager Mar 2025* now 23.8% vs 16.0% p.a. (+7.78 pp) —
Varun Pattani fund manager Mar 2025* now 23.8% vs 16.0% p.a. (+7.78 pp) —
Sameer Kate fund manager Apr 2025* now 19.2% vs 11.4% p.a. (+7.79 pp) —
Yug Tibrewal fund manager Apr 2025* now 19.2% vs 11.4% p.a. (+7.79 pp) —
Vasav Sahgal fund manager by Feb 2024† Feb 2025 1.1% vs 3.0% p.a. (−1.88 pp) —

* dated by first appearance in the archive we hold, not by a date the factsheet printed. † already named on the first factsheet we hold: the stint is at least this long, and its start is not known. Co-managed months count for every manager named; a factsheet names the manager of record, not who made each call. All managers →

The 5-year figure covers most of the fund's entire life. This scheme is about 3.2 years old and a 5-year return is being displayed for it. That is effectively a since-inception number — it measures the period the fund happened to be launched into, and separates nothing from the manager's contribution.
How it is measured, and the case against

A record earned under different people is not evidence about these ones.

Does the displayed record predate the people running it?

Why this might matterA five-year figure on a fund whose longest-serving manager joined two years ago is the house's record more than the person's. The tenure here comes from what each monthly factsheet named, so a change of hands is dated to the month it was disclosed, and the fund's return against its category can be read over exactly those months.
Why it might notEvery fund is young once, and a short record is not a bad one. This says the number cannot bear the weight usually placed on it, not that the fund is worse than a peer.

Tracking gap

the NAV the fund published, against the NAV its last disclosed portfolio would have produced at each day's prices

No signal. About 30% of this fund is outside listed Indian equity — a foreign or derivative sleeve, or debt — and there are no daily prices to replicate it with. A wrong signal would be worse than none.

Share classes

latest NAV per AMFI code

PlanOptionNAVDate
direct
quant Healthcare Fund - Growth Option - Direct Plan
growth₹19.4521 Sep 2026
direct
quant Healthcare Fund - IDCW Option - Direct Plan
idcw₹19.4521 Sep 2026
regular
quant Healthcare Fund - Growth Option - Regular Plan
growth₹18.4721 Sep 2026
regular
quant Healthcare Fund - IDCW Option - Regular Plan
idcw₹18.4721 Sep 2026
The Direct / Regular gap, in rupees
Direct growth NAV
₹19.45
Regular growth NAV
₹18.47
NAV divergence to date
5.3% — same portfolio, priced differently
Regular costs more by
1.96% a year
On ₹1,00,000 over ten years
₹1,11,967

A Regular plan buys advice. The fee is visible and the behavioural saving is not; both are shown, neither is netted off.

Compare with

same category, by size